Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This a randomized double-blind placebo controlled trial which aims to determine the
beneficial effects of minocycline augmentation to clozapine in partial responders to
Treatment Resistant Schizophrenia (TRS).
Phase:
Phase 1
Details
Lead Sponsor:
Pakistan Institute of Learning and Living Pakistan Institute of Living and Learning